Platform
Features
1 follower
Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.
Industries
Headquarters
Employees
Links
3 members
2 members
Cargo
Apogee Therapeutics
Imvax
Elektrofi
Cellares
2 followers
Thermo Fisher Scientific
148 followers
Genentech
144 followers
Gilead Sciences
121 followers
Biogen
108 followers
Regeneron
89 followers
Akari Therapeutics
Discover companies
